Nuclear expression of 14-3-3 sigma is related to prognosis in patients with esophageal squamous cell carcinoma

Anticancer Research

Volumn 30, Issue 12, 2010, Pages 5175-5180

  Okumura, Hiroshi ^a   Kita, Yoshiaki ^a   Yokomakura, Naoya ^a   Uchikado, Yasuto ^a   Setoyama, Tetsuro ^a   Sakurai, Hidetoshi ^a   Omoto, Itaru ^a   Matsumoto, Masataka ^a   Owaki, Tetsuhiro ^a   Ishigami, Sumiya ^a   Natsugoe, Shoji ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

14 3 3 sigma; Esophageal cancer; P53

Indexed keywords

PROTEIN P53; STRATIFIN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TREATMENT OUTCOME;

14-3-3 PROTEINS; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL NUCLEUS; ESOPHAGEAL NEOPLASMS; EXONUCLEASES; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 78751485963     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Yaffe MB, Rittinger K, Volinia S, Caron PR, Aitken A, Leffers, Gamblin SJ, Smerdon SJ and Cantley LC: H The structural basis for 14-3-3:phosphopeptide binding specificity. Cell 91: 961-971, 1997.
2. Qi W, Liu X, Qiao D and Martinez JD: Isoform-specific expression of 14-3-3 proteins in human lung cancer tissues. Int J Cancer 113: 359-363, 2005.
3. Fu H, Subramanian RR and Masters SC: 14-3-3 Proteins: structure, function, and regulation. Annu Rev Pharmacol Toxicol 40: 617-647, 2000.
4. Mackintosh C: Dynamic interactions between 14-3-3 proteins and phosphoproteins regulate diverse cellular processes. Biochem J 381: 329-342, 2004.
5. Mhawech P: 14-3-3 Proteins - an update. Cell Res 15: 228-236, 2005.
6. 2/M progression. Mol Cell 1: 3-11, 1997.
7. Chan TA, Hermeking H, Lengauer C, Kinzler KW and Vogelstein B: 14-3-3σ is required to prevent mitotic catastrophe after DNA damage. Nature 401: 616-620, 1999.
8. Perathoner A, Pirkebner D, Brandacher G, Spizzo G, Stadlmann S, Obrist P, Margreiter R and Amberger A: 14-3-3 Sigma expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients. Clin Cancer Res 11: 3274-3279, 2005.
9. Tanaka K, Hatada T, Kobayashi M, Mohri Y, Tonouchi H, Miki C, Nobori T and Kusunoki M: The clinical implication of 14-33 sigma expression in primary gastrointestinal malignancy. Int J Oncol 25: 1591-1597, 2004.
10. Laimer K, Blassnig N, Spizzo G, Kloss F, Rasse M, Obrist P, Schäfer G, Perathoner A, Margreiter R and Amberger A: Prognostic significance of 14-3-3 sigma expression in oral squamous cell carcinoma (OSCC). Oral Oncol 45: 127-134, 2009.
11. Mhawech P, Greloz V, Assaly M and Herrmann F: Immunohistochemical expression of 14-3-3 sigma protein in human urological and gynecological tumors using a multi-tumor microarray analysis. Pathol Int 55: 77-82, 2005.
12. Wang Z, Tropè CG, Suo Z, Trøen G, Yang G, Nesland JM and Holm R: The clinicopathological and prognostic impact of 143-3 sigma expression on vulvar squamous cell carcinomas. BMC Cancer 8: 308, 2008.
13. Sobin LH and Wittwkind CH: TNM Classification of Malignant Tumors, International Union Against Cancer, Ed. 5. New York: John Wiley & Sons, 1997.
14. Okumura H, Natsugoe S, Yokomakura N, Kita Y, Matsumoto M, Uchikado Y, Setoyama T, Owaki T, Ishigami S and Aikou T: Expression of p53R2 is related to prognosis in patients with esophageal squamous cell carcinoma. Clin Cancer Res 12: 37403745, 2006.
15. Kuroda Y, Aishima S, Taketomi A, Nishihara Y, Iguchi T, Taguchi K, Maehara Y and Tsuneyoshi M: 14-3-3 Sigma negatively regulates the cell cycle, and its down-regulation is associated with poor outcome in intrahepatic cholangiocarcinoma. Hum Pathol 55: 1014-1022, 2007.
16. Lodygin D and Hermeking H: Epigenetic silencing of 14-3-3 sigma in cancer. Semin Cancer Biol 16: 214-224, 2006.
17. Simpson PT, Gale T, Reis-Filho JS, Jones C, Parry S, Steele D, Cossu A, Budroni M, Palmieri G and Lakhani SR: Distribution and significance of 14-3-3 sigma, a novel myoepithelial marker, in normal, benign, and malignant breast tissue. J Pathol 202: 274-285, 2004.
18. Akahira J, Sugihashi Y, Suzuki T, Ito K, Niikura H, Moriya T, Nitta M, Okamura H, Inoue S, Sasano H, Okamura K and Yaegashi N: Decreased expression of 14-3-3 sigma is associated with advanced disease in human epithelial ovarian cancer: its correlation with aberrant DNA methylation. Clin Cancer Res 10: 2687-2693, 2004.
19. Ito K, Suzuki T, Akahira J, Sakuma M, Saitou S, Okamoto S, Niikura H, Okamura K, Yaegashi N, Sasano H and Inoue S: 143-3 Sigma in endometrial cancer - a possible prognostic marker in early-stage cancer. Clin Cancer Res 11: 7384-7391, 2005.